Article Details
Retrieved on: 2022-05-13 05:43:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
HC Wainwright reduced their price objective on shares of Minerva Neurosciences to $5.00 and set a “buy” rating on the stock in a research note on ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here